z-logo
Premium
Hsp90 associates with N‐terminal extended peptides and is required for direct antigen presentation
Author(s) -
Garg Manish,
Callahan Margaret K,
Srivastava Pramod K
Publication year - 2008
Publication title -
the faseb journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.709
H-Index - 277
eISSN - 1530-6860
pISSN - 0892-6638
DOI - 10.1096/fasebj.22.1_supplement.1067.19
Subject(s) - mhc class i , epitope , antigen presentation , hsp90 , lactacystin , antigen , major histocompatibility complex , t cell , chemistry , antigen processing , chaperone (clinical) , microbiology and biotechnology , endoplasmic reticulum , cytosol , peptide , cytotoxic t cell , proteasome , biochemistry , heat shock protein , biology , proteasome inhibitor , immune system , immunology , in vitro , enzyme , medicine , pathology , gene
Antigen presentation by MHC I molecules requires the generation of peptides in the cytosol, ferrying of peptides from cytosol to endoplasmic reticulum, loading of MHC I with peptides, and transport of MHC I‐peptide complexes to the cell surface. Hsp90 is a cytosolic chaperone known to associate with peptide and peptide precursors of MHC I epitopes. We report here that treatment of a variety of cells with hsp90 inhibitors leads to generation of “empty” MHC I molecules on the cell surface, due to inhibited loading of MHC I with peptides. Inhibition of hsp90 does not inhibit protein synthesis in general, nor synthesis of MHC I in particular, nor does it affect the activity of proteasomes. Hsp90‐inhibited cells, like lactacystin‐treated cells, are poor stimulators of T lymphocytes. The role of hsp90 in presentation of an ovalbumin epitope is shown to be at a post‐proteasomal step: hsp90 associates with N‐terminally extended precursors of the SIINFEKL epitope, and such peptides are depleted from hsp90 preparations in inhibitor‐treated cells. These results argue for a substantial role for hsp90 in chaperoning of antigenic peptides in direct presentation. This work was supported by NIH grant CA 084479 to P.K.S.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here